BATS BZX Real-Time Price
As of 2:03pm ET
 -2.20 / -3.07%
Today’s Change
Today|||52-Week Range
Inogen Fails 10-K Deadline; Files Form 12b-25 for Extra Time - Analyst Blog
1:17pm / Zacks.com
Can The Uptrend Continue for ABIOMED (ABMD)? - Tale of the Tape
Mar 26 / Zacks.com
Varian Medical: A Strong Sell on Tepid View, Estimate Revision - Analyst Blog
1:17pm / Zacks.com
Allscripts and Drexel University Extend EHR Alliance - Analyst Blog
Mar 25 / Zacks.com
Luminex (LMNX) Commences Clinical Trials for ARIES System - Analyst Blog
Mar 31 / Zacks.com
Abiomed Attains New 52-Week High on Impella 2.5 Approval - Analyst Blog
Mar 25 / Zacks.com
Cepheid Ships Record Xpert MTB/RIF to Mark World TB Day - Analyst Blog
Mar 30 / Zacks.com
Today's Perilous Reversal Stock: Abiomed (ABMD)
Mar 25 / TheStreet.com
Adeptus Health Hits 52-Week High on Top-Line Strength - Analyst Blog
Mar 30 / Zacks.com
ABIOMED (ABMD) in Focus: Stock Surges 18% in Session - Tale of the Tape
Mar 25 / Zacks.com
Varian (VAR) Showcases Edge Radiosurgey at 2015 ChinaMed - Analyst Blog
Mar 27 / Zacks.com
Why Abiomed, Inc. is Soaring Higher Today
Mar 24 / MotleyFool.com
Hanger Goes Downhill on Moody's Rating Cut, NYSE Notice - Analyst Blog
Mar 27 / Zacks.com
Abiomed's Impella 2.5 FDA-Approved for PCI Procedures - Analyst Blog
Mar 24 / Zacks.com
Cepheid's Xpert Ebola Gets FDA's Nod for Emergency Use - Analyst Blog
Mar 27 / Zacks.com
ERBA Diagnostics (ERB) Rises: Stock Adds 5.3% in Session - Tale of the Tape
Mar 20 / Zacks.com
Zacks Industry Outlook Highlights: Boston Scientific, Edwards Lifesciences, Natus Med...
Mar 27 / Zacks.com
Varian Opens New Unit in Algeria, Consolidates in North Africa - Analyst Blog
Mar 19 / Zacks.com
Inogen's Texas Facility Ready, Costs Likely to Scale Down - Analyst Blog
Mar 26 / Zacks.com
Edwards Lifesciences Up on Positive PARTNER Trial Data - Analyst Blog
Mar 18 / Zacks.com
MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
Mar 26 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account